Investment in AI is rapidly becoming ROI positive for various industries, including banking and pharmaceuticals. The challenge lies in how model producers will see returns on their foundational models. As inference costs decrease and capabilities improve, the potential for significant economic benefits in AI continues to grow, suggesting a promising future for model providers.